Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Football Matches on the Emergency Admissions of a Level III Maternity During EURO 2016

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03984617
Recruitment Status : Completed
First Posted : June 13, 2019
Last Update Posted : June 13, 2019
Sponsor:
Information provided by (Responsible Party):
Central Hospital, Nancy, France

Brief Summary:

Attendances at an emergency department (ED) are often considered to depend on different factors such as moonlight, welfare checks, weather, and major sporting events. Data regarding effects of large sporting events on the workload of ED often assessed decreased patient volume, especially male use. Currently, no data are available on the effect of major televised sporting events on obstetrical visits. The aim of this study is to examine whether televised soccer games from a major sporting tournament, (Euro 2016) influence the level of attendance at an obstetrical ED and could have implications for women's welfare.

In the summer of 2016, France hosted the largest European sporting event of the year 2016: the European Football Championships (Euro 2016). A total of 51 games were played over a month, bringing together the biggest European teams. An observational, retrospective study is conducted during this period on the number of emergency visits in a French tertiary Maternity hospital (Maternity of Nancy).


Condition or disease Intervention/treatment
Gynecologic Disease Other: Emergency visit in a French tertiary Maternity hospital (Maternity of Nancy)

Layout table for study information
Study Type : Observational
Actual Enrollment : 1114 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Impact of Football Matches on the Emergency Admissions of a Level III Maternity During EURO 2016
Actual Study Start Date : June 10, 2016
Actual Primary Completion Date : July 10, 2016
Actual Study Completion Date : July 10, 2016

Intervention Details:
  • Other: Emergency visit in a French tertiary Maternity hospital (Maternity of Nancy)
    total number of visits (hospitalizations and consultations)


Primary Outcome Measures :
  1. Overall number of maternity emergencies admissions during EURO 2016 (10June-10July) [ Time Frame: At the end of EURO 2016 on 10th July 2016 ]

Secondary Outcome Measures :
  1. Number of daily admissions and per 2 hours time slot every day from June 10th to July 10th [ Time Frame: At the end of EURO 2016 on 10th July 2016 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
All patients admitted to emergencies are informed of the protocol and a questionnaire is provided by the care team.
Criteria

Inclusion Criteria:

All female patients admitted urgently to the Regional Maternity Hospital between June 10 and July 10, 2016

Exclusion Criteria:

  • refusal of the patient
  • information and understanding impossible

Layout table for additonal information
Responsible Party: Central Hospital, Nancy, France
ClinicalTrials.gov Identifier: NCT03984617     History of Changes
Other Study ID Numbers: PSS 2016/EURO-VIAL/ER
First Posted: June 13, 2019    Key Record Dates
Last Update Posted: June 13, 2019
Last Verified: June 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Genital Diseases, Female
Emergencies
Disease Attributes
Pathologic Processes